HEMATOLOGICAL MALIGNANCY
Clinical trials for HEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cord blood cells engineered to fight Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a new treatment using immune cells (NK cells) from donated cord blood that are engineered to target a protein called CD5 found on certain cancer cells. The treatment is given after chemotherapy to prepare the body, and the goal is to see if it is safe and effecti…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 11:55 UTC
-
Half-Matched stem cell transplant offers hope for blood cancer patients
Disease control Recruiting nowThis study tests a stem cell transplant using a half-matched (haploidentical) donor for people with blood cancers who don't have a fully matched donor. The approach uses chemotherapy and radiation before transplant, plus drugs like cyclophosphamide and bortezomib after to prevent…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE2 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC